UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
6-K
REPORT
OF FOREIGN PRIVATE ISSUER
PURSUANT
TO RULE 13a-16 OR 15d-16
UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For
the month of November 2026
Mobile-health
Network Solutions
2
Venture Drive, #07-08 Vision Exchange
Singapore
608526
+65
6222 5223
(Address,
including zip code, and telephone number, including area code, of Registrant’s principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form
20-F ☒ Form 40-F ☐
Entry
into an Amendment to Standby Equity Subscription Agreement
As
previously disclosed on February 19, 2025, on February 14, 2025, Mobile-health Network Solutions (the “Company”) entered
into a standby equity purchase agreement (the “Purchase Agreement”) with YA II PN, Ltd. (“Yorkville”), pursuant
to which the Company shall have the right, but not the obligation, to issue to Yorkville, and Yorkville shall have the obligation to
subscribe for, Class A ordinary shares in the capital of the Company par value $0.00096 per share (the “Ordinary Shares”)
for an aggregate subscription amount of up to $10,000,000, at any time during the commitment period of 36 months from February 14, 2025,
subject to certain conditions. As of November 11, 2026, Yorkville had purchased $5,488,935 of Ordinary Shares under the Purchase Agreement.
On
November 11, 2026 (the “Amendment Effective Date”), the Company entered into an amendment to the Purchase Agreement (the
“Amendment”; the Purchase Agreement, as amended by the Amendment, the “SEPA”) with Yorkville, pursuant
to which the Company shall have the right, but not the obligation, to issue to Yorkville, and Yorkville shall have the obligation to
subscribe for, Ordinary Shares for an aggregate subscription amount of up to $30 million (the “Commitment Amount”), at any
time before December 31, 2028, subject to certain conditions.
As
consideration for Yorkville’s increased subscription commitment, the Company will pay an additional commitment fee equal to 1.00%
of the $20,000,000 increase in the Commitment Amount, or $200,000, within three days of the Amendment Effective Date, at the Company’s
option, either in cash or by the Company’s issuance to Yorkville of 200,000 Ordinary Shares.
The
SEPA shall terminate automatically on the earliest of (i) December 31, 2028 or (ii) the date on which Yorkville shall have made payment
of Advances pursuant to the SEPA for Ordinary Shares equal to the Commitment Amount. The Company may terminate the SEPA effective upon
five Trading Days’ prior written notice to Yorkville; provided that (i) there are no outstanding Advance Notices, the Ordinary
Shares under which have yet to be issued, and (ii) the Company has paid all amounts owed to Yorkville pursuant to the SEPA. The SEPA
may be terminated at any time by the mutual written consent of the parties, effective as of the date of such mutual written consent unless
otherwise provided in such written consent.
Except
as modified by the Amendment, the terms and conditions of the Purchase Agreement remain in full force and effect.
The
SEPA contains customary representations, warranties, covenants, closing conditions and indemnification provisions. Sales under the SEPA
may commence only after certain conditions have been satisfied, including the effectiveness of a registration statement on Form F-1 to
be filed by the Company covering the resale of the ordinary shares issued or to be sold by the Company to Yorkville under the SEPA (the
“Registration Statement”).
The
proceeds from the sale of the Ordinary Shares by the Company to Yorkville shall be used by the Company in the manner as will be set forth
in the Prospectus included in any Registration Statement (and any post-effective amendment thereto) and any Prospectus Supplement thereto
filed pursuant to this Agreement. Neither the Company nor any Subsidiary will, directly or indirectly, use the proceeds of the transactions
contemplated herein, or lend, contribute, facilitate or otherwise make available such proceeds to any Person (i) to fund, either directly
or indirectly, any activities or business of or with any Person that is identified on the list of Specially Designated Nationals and
Blocker Persons maintained by OFAC, or in any country or territory, that, at the time of such funding, is, or whose government is, the
subject of Sanctions or Sanctions Programs, or (ii) in any other manner that will result in a violation of Sanctions or Applicable Laws.
The
foregoing description of the SEPA does not purport to be complete and is qualified in its entirety by the terms and conditions of the
Amendment, the form of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
EXHIBIT
INDEX
| Exhibit
No. |
|
Description |
99.1 |
|
Amendment to Standby Equity Purchase Agreement, dated November 11, 2026, by and between the Company and YA II PN, Ltd. |
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
| |
Mobile-health
Network Solutions |
| |
|
|
| Date:
November 17, 2026 |
By: |
/s/
Siaw Tung Yeng |
| |
Name: |
Siaw
Tung Yeng |
| |
Title: |
Co-Chief
Executive Officer |
Exhibit 99.1
AMENDMENT
TO STANDBY EQUITY PURCHASE AGREEMENT
This
AMENDMENT TO THE STANDBY EQUITY PURCHASE AGREEMENT, dated as of November 11, 2026 (this “Amendment”), is entered
between MOBILE-HEALTH NETWORK SOLUTIONS, a Cayman Islands company (the “Company”), and YA II PN, LTD.,
a Cayman Islands exempt limited partnership (the “Investor”).
PRELIMINARY
STATEMENTS
A.
Reference is hereby made to that certain Standby Equity Purchase Agreement, dated as of February 14, 2025 (as may be further amended,
amended and restated, extended, supplemented or otherwise modified in writing from time to time and in effect immediately prior to the
effectiveness of this Amendment, the “Existing Agreement”, and the Existing Agreement, as amended by this Amendment,
the “Amended Agreement”), between the Company and the Investor.
B.
The Commitment Amount of the Existing Agreement is $10,000,000 of Ordinary Shares. As of the date of this Amendment the Investor
has purchased $5,488,935 of Ordinary Shares and $4,511,064 of the Commitment Amount remains available.
C.
The parties desire to amend certain of the terms and provisions of the Existing Agreement as specifically set forth in this Amendment,
including to increase the Commitment Amount by $20,000,000 (the “Commitment Amount Increase”) to an aggregate of $30,000,000.
D.
The parties are prepared to amend the Existing Agreement, subject to the conditions and in reliance on the representations set forth
in this Amendment.
Accordingly,
in consideration of the premises and the mutual covenants contained herein, and other good and valuable consideration, the receipt and
adequacy of which are hereby acknowledged, the parties hereto agree as follows:
SECTION
1. Defined Terms. Unless otherwise defined herein, all capitalized terms used herein, including in preamble and the preliminary
statements hereto, shall have the meanings assigned to such terms in the Existing Agreement.
SECTION
2. Amendments to Existing Agreement. Subject to the satisfaction of the conditions precedent specified in Section 3
and in reliance upon the representations and warranties set forth in Section 4, the Existing Agreement is hereby amended as follows:
(a)
Section 9.01(a) of the Existing Agreement is hereby amended and restated in its entirety as follows:
“(a)
Unless earlier terminated as provided hereunder, this Agreement shall terminate automatically on the earliest of (i) December 31, 2028,
or (ii) the date on which the Investor shall have made payment of Advances pursuant to this Agreement for Ordinary Shares equal to the
Commitment Amount.”
(b)
The Definition of the term “Commitment Amount” as defined in Annex I to the Existing Agreement is hereby amended and restated
in its entirety as follows:
“Commitment
Amount” shall mean $30,000,000 of Ordinary Shares.
SECTION
3. Conditions Precedent to Effectiveness of Amendment. This Amendment shall become effective as of the date first written
above (the “Amendment Effective Date”) upon satisfaction of each of the following conditions precedent (except to
the extent such conditions precedent are subject to Section 4):
(a)
Amendment. This Amendment shall have been duly executed and delivered by each party.
SECTION
4. Representations and Warranties. Each party represents and warrants that:
(a)
Authorization; No Contravention. The execution, delivery and performance by such party of this Amendment (i) have been duly and
validly authorized by all corporate, stockholder, partnership or limited liability company action required to be taken by such party,
and (ii) do not violate or contravene such party’s governing documents or any applicable law or any material agreement or instrument
or any court order which is binding upon such party or its property.
(b)
Enforceability. This Amendment, and the Amended Agreement is a legal, valid and binding obligation of such party, enforceable
against it in accordance with its terms, except as enforceability may be limited by bankruptcy, insolvency or similar laws affecting
the enforcement of creditors’ rights generally and by general equitable principles.
SECTION
5. Survival of Representations and Warranties. All representations and warranties made in this Amendment shall survive the
execution and delivery of this Amendment. Such representations and warranties have been or will be relied upon by the parties and shall
continue in full force and effect as long as any obligation under the Amended Agreement shall remain unpaid or unsatisfied.
SECTION
6. Effect of Amendment, Other Agreements, Etc.
(a)
Effect of Amendment. After giving effect to this Amendment on the Amendment Effective Date, the Amended Agreement shall be and
remain in full force and effect in accordance with its terms and is hereby ratified and confirmed by the parties in all respects. The
execution, delivery, and performance of this Amendment shall not operate as a waiver of any right, power, or remedy of any party under
the Existing Agreement. Each party hereby acknowledges and agrees that, after giving effect to this Amendment, all of its obligations
and liabilities under the Existing Agreement to which it is a party, as such obligations and liabilities have been amended by this Amendment,
are reaffirmed and remain in full force and effect. All references to the Existing Agreement in any document or instrument delivered
in connection therewith shall be deemed to refer to the Amended Agreement. Nothing contained herein shall be construed as a novation
of the obligations outstanding under the Existing Agreement, which shall remain in full force and effect, except as modified hereby.
(b)
Limited Effect. This Amendment relates only to the specific matters expressly covered herein, shall not be considered to be an
amendment or waiver of any rights or remedies that any party may have under the Existing Agreement or under applicable law, and shall
not be considered to create a course of dealing or to otherwise obligate in any respect a party to execute similar or other amendments
or waivers or grant any amendments or waivers under the same or similar or other circumstances in the future.
(c)
SEC Filings. The Company shall, as soon as practicable following the date hereof, publicly disclose in an SEC filing all the material
terms and transactions contemplated by this Amendment. Prior to the delivery of any Advance Notices pursuant to the Amended Agreement,
the Company shall prepare and file with the SEC a Registration Statement for the resale by the Investor of the Registrable Securities.
The Company shall not have the ability to request any Advances under the Amended Agreement until the effectiveness of such Registration
Statement.
(d)
Commitment Fee. The Company shall pay a commitment fee in an amount equal to 1.00% of the Commitment Amount Increase (the “Additional
Commitment Fee”) within three days of the Amendment Effective Date, at the Company’s option, either in cash or by the
issuance to the Investor of 200,000 Ordinary Shares (the “Additional Commitment Shares”). Any Additional Commitment
Shares issued hereunder shall be included on the next Registration Statement.
SECTION
7. Miscellaneous.
(a)
Headings. Section headings in this Amendment are included herein for convenience and do not affect the meanings of the provisions
that they precede.
(b)
Severability. If any provision of this Amendment is held invalid or unenforceable, either in its entirety or by virtue of its
scope or application to given circumstances, such provision shall thereupon be deemed modified only to the extent necessary to render
same valid, or not applicable to given circumstances, or excised from this Amendment, as the situation may require, and this Amendment
shall be construed and enforced as if such provision had been included herein as so modified in scope or application, or had not been
included herein or therein, as the case may be.
(c)
Binding Effect. This Amendment binds and is for the benefit of the successors of each party.
(d)
GOVERNING LAW. THIS AMENDMENT SHALL BE GOVERNED BY AND INTERPRETED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK WITHOUT
REGARD TO THE PRINCIPLES OF CONFLICT OF LAWS. THE PARTIES FURTHER AGREE THAT ANY ACTION BETWEEN THEM SHALL BE HEARD IN NEW YORK COUNTY,
NEW YORK, AND EXPRESSLY CONSENT TO THE JURISDICTION AND VENUE OF THE SUPREME COURT OF NEW YORK, SITTING IN NEW YORK COUNTY, NEW YORK
AND THE UNITED STATES DISTRICT COURT OF THE SOUTHERN DISTRICT OF NEW YORK, SITTING IN NEW YORK, NEW YORK, FOR THE ADJUDICATION OF ANY
CIVIL ACTION ASSERTED PURSUANT TO THIS AMENDMENT.
(e) Execution
in Counterparts. This Amendment may be executed in identical counterparts, both which shall be considered one and the same agreement
and shall become effective when counterparts have been signed by each party and delivered to the other party. Facsimile or other electronically
scanned and delivered signatures, including by e-mail attachment, shall be deemed originals for all purposes of this Amendment.
[Remainder
of Page Intentionally Left Blank; Signature Pages Follow]
IN
WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed and delivered as of the date first above written.
| |
Mobile-health
Network Solutions |
| |
|
|
| |
By: |
/s/ Siaw Tung Yeng |
| |
Name: |
Siaw Tung Yeng |
| |
Title: |
Chief Executive Officer |
[Signature
Page to Amendment to Standby Equity Purchase Agreement]
| |
YA II PN, LTD. |
| |
|
|
| |
By: |
Yorkville Advisors Global, LP |
| |
Its: |
Investment Manager |
| |
By: |
Yorkville Advisors Global II, LLC |
| |
Its: |
General Partner |
| |
By: |
/s/ Matt Beckman |
| |
Name: |
Matt Beckman |
| |
Title: |
Member |
[Signature
Page to Amendment to Standby Equity Purchase Agreement]